A pilot-controlled study of myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody (MPO-ANCA) in the coronary circulation

Int J Cardiol. 2008 Aug 1;128(1):114-6. doi: 10.1016/j.ijcard.2007.04.119. Epub 2007 Jul 20.

Abstract

Hereby we report our observations derived from a pilot-study of 39 subjects (30 patients with coronary artery disease [CAD] and 9 non-CAD controls). In this work, we aimed to evaluate MPO-ANCA titer in the human coronary circulation for the first time; and examine its possible association with CAD and some cytokines/inflammatory markers. We found higher mean coronary MPO-ANCA titer in CAD subjects than in non-CAD controls; beside significant positive correlations between MPO-ANCA titers and both C-reactive protein and interleukin-6 levels. Thus, we might suggest the possible involvement of MPO-ANCA in coronary atherogenesis indirectly through modulating some pro-inflammatory cytokines/markers; that a large-scale study of MPO-ANCA in CAD patients may be warranted in the future.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Antineutrophil Cytoplasmic / blood*
  • Biomarkers / blood
  • C-Reactive Protein / metabolism
  • Case-Control Studies
  • Coronary Circulation*
  • Coronary Disease / immunology*
  • Female
  • Humans
  • Interleukin-6 / blood
  • Male
  • Middle Aged
  • Peroxidase / immunology
  • Pilot Projects
  • Risk Factors

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Biomarkers
  • Interleukin-6
  • C-Reactive Protein
  • Peroxidase